Cresset Asset Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,938
| Closed | -$287K | – | 1886 |
|
|
2024
Q3 | $287K | Buy |
4,938
+37
| +0.8% | +$2.15K | ﹤0.01% | 1787 |
|
|
2024
Q2 | $224K | Sell |
4,901
-26
| -0.5% | -$1.19K | ﹤0.01% | 1811 |
|
|
2024
Q1 | $326K | Sell |
4,927
-2,249
| -31% | -$149K | ﹤0.01% | 1520 |
|
|
2023
Q4 | $285K | Sell |
7,176
-506
| -7% | -$20.1K | ﹤0.01% | 1487 |
|
|
2023
Q3 | $245K | Hold |
7,682
| – | – | ﹤0.01% | 1494 |
|
|
2023
Q2 | $309K | Buy |
+7,682
| New | +$309K | ﹤0.01% | 1374 |
|